M.V.I.-12 (Hospira Worldwide, Inc.)
Welcome to the PulseAid listing for the M.V.I.-12 drug offered from Hospira Worldwide, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira Worldwide, Inc. |
NON-PROPRIETARY NAME: | retinol, ergocalciferol, .alpha.-tocopherol acetate, dl-, ascorbic acid, niacinamide, riboflavin 5-phosphate sodium, thiamine hydrochloride, pyridoxine hydrochloride, dexpanthenol, biotin, folic acid, |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-01-12 |
END MARKETING DATE: | 0000-00-00 |
M.V.I.-12 HUMAN PRESCRIPTION DRUG Details:
Item Description | M.V.I.-12 from Hospira Worldwide, Inc. |
LABELER NAME: | Hospira Worldwide, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2005-01-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61703-423_e59c5b35-4dc0-4107-aba8-245a34139b95 |
PRODUCT NDC: | 61703-423 |
APPLICATION NUMBER: | NDA008809 |